NCT04769817View on ClinicalTrials.gov

ProsTIC Registry of Men Treated With PSMA Theranostics

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2028

Conditions
Prostate CancerMetastatic Castration-resistant Prostate Cancer
Interventions
OTHER

177Lu-PSMA

Lu-PSMA will be administered as a standard-of-care procedure following assessment of suitability by a nuclear medicine physician and managed in close collaboration with the patient's medical oncologist.

Trial Locations (1)

3000

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

All Listed Sponsors
lead

Peter MacCallum Cancer Centre, Australia

OTHER